Diurnal variation in concentrations of various markers of bone metabolism in dogs

American Journal of Veterinary Research

Volumn 60, Issue 8, 1999, Pages 949-953

  Liesegang, Annette ^a   Reutter, Regula ^a   Sassi, Mirja Liisa ^b   Risteli, Juha ^b   Kraenzlin, Marius ^c   Riond, J L ^a   Wanner, Marcel ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; BIOLOGICAL MARKER; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; CREATININE; DEOXYPYRIDINOLINE; HYDROXYPROLINE; OSTEOCALCIN; PEPTIDE; PYRIDINOLINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD ANALYSIS; BONE; CIRCADIAN RHYTHM; COLORIMETRY; DOG; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; RADIOIMMUNOASSAY; REFERENCE VALUE; URINE;

ALKALINE PHOSPHATASE; AMINO ACIDS; ANIMALS; BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; BONE AND BONES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CIRCADIAN RHYTHM; COLLAGEN; COLLAGEN TYPE I; COLORIMETRY; CREATININE; DOGS; FEMALE; HYDROXYPROLINE; OSTEOCALCIN; PEPTIDES; RADIOIMMUNOASSAY; REFERENCE VALUES;

EID: 0033172857     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cahoon S, Boden SD, Gould KG, et al. Noninvasive markers of bone metabolism in the rhesus monkey: normal effects of age and gender. J Med Primatol 1996;25:333-338.
2. Egger CD, Mühlbauer RC, Felix R, et al. Evaluation of urinary pyridinium crosslink excretion as a marker of bone resorption in the rat. J Bone Miner Res 1994;9:1211-1219.
3. Risteli L, Risteli J. Assays of type I procollagen domains and collagen fragments: problems to be solved and future trends. Scand J Clin Lab Invest 1997;57(suppl):105-113.
4. Scott D, Abu Damir H, Buchan W, et al. Factors effecting urinary pyridinoline and deoxypyridinoline excretion in the growing lamb. Bone 1993;14:807-811.
5. Liesegang A, Sassi M-L, Risteli J, et al. Comparison of bone resorption markers during hypocalcemia in dairy cows. J Dairy Sci 1998;81:2614-2622.
6. Allen MJ, Hofmann WE, Richardson DC, et al. Serum markers of bone metabolism in dogs. Am J Vet Res 1998;59:250-254.
7. Russel RGG. The assessment of bone metabolism in vivo using biochemical approaches. Horm Metab Res 1997;29:138-144.
8. Garnero P, Delmas PD. Measurements of biochemical markers: methods and limitations. In: Bilezikian JP, Raisz LG, Rodan GA, eds. Principles of bone biology. 1st ed. San Diego: Academic Press Inc, 1996;1277-1291.
9. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium cross-links of collagen in urine using ion-paired reversed phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
10. Robins SP, Black D, Paterson CR, et al. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin invest 1991;21:310-315.
11. Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 1992;3:263-270.
12. Thompson PW, Spector TD, Edwards AO, et al. Urinary deoxypyridinoline and serum osteocalcin as measures of bone metabolism in early postmenopausal women: distribution and comparison with other measures. In: Christiansen C, Overgaard K, eds. Osteoporosis. Copenhagen: Osteopress, 1990;493-495.
13. Uebelhart D, Gineyts E, Chapuy M-C, et al. Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87-96.
14. Withold W. Monitoring of bone turnover: Biological, preanalytical and technical criteria in the assessment of biochemical markers. Eur J Clin Chem 1996;34:785-799.
15. Eyre DR, Paz MA, Gallop PM. Crosslinking in collagen and elastin. Ann Rev Biochem 1996;53:717-748.
16. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993;25:385-393.
17. Charles P, Mosekilde L, Risteli L, et al. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner 1994;24: 81-94.
18. Eriksen EF, Charles P, Melsen F, et al. Serum markers of type 1 collagen formation and degradation in metabolic bone disease. Correlation to bone histomorphometry. J Bone Miner Res 1993;8: 127-132.
19. Risteli J, Elomaa I, Niemi S, et al. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-640.
20. Hassager C, Risteli J, Risteli L, et al. Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women. J Bone Miner Res 1992;7:1307-1311.
21. Mühlbauer RC, Fleisch H. The diurnal rhythm of bone resorption in the rat. J Clin Invest 1995;95:1933-1940.
22. Saggese G, Baroncelli GI, Bertelloni S, et al. Twenty-four-hour osteocalcin, carboxy terminal propeptide of type 1, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children. Pediatric Res 1994;35:409-415.
23. Schlemmer A, Hassager C, Jensen SB, et al. Marked diurnal variation in urinary excretion of pyridinium cross-links in premenopausal women. J Clin Endocrinol Metab 1992;74:476-480.
24. Aoshima H, Kushida K, Takahashi M, et al. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Bone 1998; 22:73-78.
25. Gindler EM, King JD. Rapid colorimetric determination of calcium in biologic fluids with methylthymol blue. Am J Clin Pathol 1972;58:376-382.
26. Daly JA, Ertinghausen G. Direct method for determining inorganic phosphate in serum with the "CENTRIChem." Clin Chem 1972;18:263-265.
27. Wong HK. Fully automated procedure for serum magnesium. Clin Chem 1975;21:169.
28. Bergman I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Chem 1963;35:1961-1963.
29. Gundberg CM, Makkowitz ME, Mizruchi M, et al. Osteocalcin in human serum: a circadian rhythm. J Clin Endocrinol Metab 1985;60:736-739.
30. Lepage OM, DesCôteaux L, Marcoux M, et al. Circadian rhythms of osteocalcin in equine serum. Correlation with alkaline phosphatase, calcium, phosphate and total protein. Can J Vet Res 1991;55:5-10.
31. Corlett SC, Couch M, Care AD, et al. Measurement of plasma osteocalcin in sheep: assessment of circadian variation, the effects of age and nutritional status and the response to perturbation of the adrenocortical axis. Exp Physiol 1990;75:515-527.
32. Simmons DJ, Whiteside LA, Whitson SW. Biorhythmic profiles in the rat skeleton. Metab Bone Dis Relal Res 1979;2:49-64.
33. Deftos LJ, Parthmore JG, Price PA. Changes in plasma bone GLA protein during treatment of bone disease. Calcif Tissue Int 1982;34:121-124.
34. Nielsen HK, Charles P, Mosekilde L. The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 1988;65:290-294.
35. Syakalima M, Takiguchi M, Yasuda J, et al. Separation and quantification of corticosteroid-induced, bone and liver alkaline phosphatase isoenzymes in canine serum. Zentralbl Veterinarmed [A] 1997;44:603-610.
36. Jubiz W, Canterbury JM, Reiss E, et al. Circadian rhythm in serum parathyroid hormone concentration in human subjects: correlation with serum calcium, phosphate, albumin and growth hormone levels. J Clin Invest 1972;51:2040-2046.
37. Robins SP, Stewart P, Astbury C, et al. Measurement of the crosslinking compound, pyridinoline, in urine as an index of collagen degradation. Ann Rheum Dis 1986;45:969-973.
38. Okada M, Minura T. Zur physiologie und pharmakologie der hartgewebe .J Med Sci Pharmkol 1940:13;95-96.
39. Simmons DJ. Daily rhythm of S-35 incorporation into epiphyseal cartilage in mice. Experientia 1968;24:363-364.